News
DSM and Brains Bioceutical form exclusive global partnership to unlock the therapeutic potential of cannabinoids in early-stage drug development
Royal DSM, a global science-based company active in Nutrition, Health and Sustainable Living, announces it has entered into an exclusive commercial partnership with global leader and pioneer in cannabinoid active pharmaceutical ingredients (APIs), Brains Bioceutical. The partnership extends DSM’s...
News
Takeda, RCPE, InSilicoTrials and the University of Graz partner up to optimize manufacturing process of biopharmaceuticals
Biopharmaceuticals are large and complex drugs that mimic the action of the molecular mechanisms in living organisms. In the past decade, the number of deaths due to cancer and HIV/AIDS have been significantly reduced and the treatment of several...
News
Cold Chain Technologies Announces Further Global Expansion Into Latin America
Cold Chain Technologies, an ISO 9001:2015 certified global leader with more than 50 years developing and delivering smart solutions that protect the integrity of temperature-sensitive products, announced an extensive expansion into Latin America. The company has been operating out...
News
Andaman7 delivers step change strategy to global debate on digital health opportunities for Africa
With Africa emerging as the new breeding ground for innovative digital health solutions, an expert panel of global development and digital health leaders, including Vincent Keunen, Founder and CEO of Belgian American ehealth company Andaman7, will deliver a webinar...
News
Trialbee and uMotif Simplify and Expand Patient Access to Global Clinical Trials
The increasing need for speed and efficiency in clinical research has created more urgency to streamline and simplify the patient journey. Trialbee, a patient matching and enrolment platform, and uMotif, a patient-centric data capture provider, are partnering to improve...
News
Exscientia Acquires Personalised Medicine AI Pioneer Allcyte
Exscientia, a clinical stage pharmatech company, has entered into a binding agreement to acquire Allcyte, a leader in artificial intelligence (AI) based precision medicine. The combination expands Exscientia’s translational capabilities by enabling high content evaluation of individual patient biology...
News
Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN
Ocugen, Inc., a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, announced that it has entered into an agreement with Jubilant HollisterStier of Spokane,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read